glycine ratio above the normal level (0.04). Standard treatment strategies include the reduction of the plasma concentration of glycine, the use of N-methyl-D-aspartate (NMDA) receptor site antagonists, and the symptomatic care to control intractable seizures in addition to antiepileptic drugs. 7 The current study presented a new case of NKH.
Case Presentation
The present study introduced a neonate (girl) with poor feeding and hypotonia in the first day after birth. She was the result of a normal vaginal delivery at 38 weeks of age. Her mother was 32 years old and her obstetrics history was G5, P4, and Ab1 that the last child was a boy who died 25 days after birth. The patient was evaluated in terms of hypotonia and poor feeding. In primary lab dates, the obtained data were as follows:
The blood sugar, creatinine, and blood urea nitrogen were normal, white blood cell = 15 000 ×10 3 /mm 3 , hemoglobin = 18.3 mg/dL, and platelet was 270 ×10 3 / mm 3 . Serum sodium, potassium, magnesium, and calcium concentrations were normal as well. The neonatal-onset NKH was diagnosed based on a noticeably elevated CSF/plasma glycine ratio of 0.32 (the normal ratio is less than 0.08) with a CSF glycine of 162 mol/L (normal range = 1.6-19.5 mol/L) and plasma glycine of 1136 mol/L (normal range = 224-514 mol/L). Urine glycine levels were also markedly elevated at 41,752 mol/g creatinine (normal range = 0-7047 mol/g creatinine).
The diagnosis was confirmed by mutation testing that demonstrated the homozygous mutation of the glycine decarboxylase (GLDC) gene encoding for the P-protein of the glycine cleavage system complex. Unfortunately, despite the patient's admission to the neonatal intensive care unit and supportive care, the patient died on the 14th day after birth.
Discussion and Conclusion
As it is known, the NKH is an uncommon metabolic disorder in children. It is caused due to a defect in the glycine cleavage system, which is a multi-enzyme complex of four proteins like P, H, T, and L-protein included a pyridoxal phosphate-dependent glycine decarboxylase, a lipoic acid-containing protein, a tetrahydrofolate-requiring enzyme, and a lipoamide dehydrogenase, respectively. The code for these proteins is located in GLDC, GCSH, and AMT genes, respectively. Further, the P-, T-, H-and L-protein genes are on chromosome nine and its short arm. The defects in any of these enzymes can lead to NKH, but P protein deficiency is considered as its most common form that is observed in 80% of patients. 8 The accumulation of glycine in the CNS and other body fluids is the characteristic of this syndrome. The glycine function as an inhibitory neurotransmitter in the brain stem and spinal cord, as well as stimulatory effects through NMDA receptors. Infants developing this syndrome experience neurological symptoms due to high levels of glycine in their cerebrospinal fluid. It seems that apnea and hiccups in these infants are due to the inhibitory effects of glycine in the spinal cord and brain stem. On the other hand, refractory seizures in these patients are attributed to the effects of the activation of NMDA receptors by glycine. In some patients, hypotonicity, decreased neonatal reflexes, myoclonic seizures, and hiccups are reported as well. 9 In 2011 a newborn was identified by the diagnosis of NKH and MRI and MR spectroscopic was done for the patient at six days of age, followed by investigating the radiologic findings in this patient. 10 Furthermore, Kaźmierczuk-Skubis et al introduced a neonate diagnosed with NKH, who was presented with seizures in the first 24 hours of life. To diagnose NKH in this patient, all other causes of seizure were rolled out, and the diagnosis of NKH was proved with high concentrations of glycine in the blood and the symptoms of the patient such as hypotonicity, as well as the imaging of the central nervous system. 11 Moreover, Chang et al reported a newborn baby with a classic neonatal form of NKH that included hiccups and muscle tone reduction and then used genetic testing to confirm the diagnosis. 12 Similarly, Panayiotou et al reported a newborn with respiratory problems who needed intubation and mechanical ventilation during the treatment. The examination of respiratory data showed that the patient had multiple hiccups during mechanical ventilation. NKH was diagnosed during further studies and metabolic screening for the patient. 13 In another study, Chiu et al evaluated the NKH of the infants in Taiwan, including 11 infants and 2 neonatal NKH infants had a mutation in the GLDC gene, 14 which is similar to a mutation that we found in our patient. In the other case report in Iran, Danaei et al provided data about a 4-dayold girl with hypotonia, lethargy, seizures, and poor sucking and high levels of glycine in blood and urine were reported in more evaluations, confirming the diagnosis of NKH. 15 The current study also presented a newborn girl with neonatal-onset NKH with poor feeding and hypotonia, therefore, it is very important to consider this diagnosis in infants with poor feeding and hypotonia.
